Original article
Maternal uniparental disomy 14 revealed by alpha 1 antitrypsin deficiency

https://doi.org/10.1016/j.clinre.2014.01.011Get rights and content

Summary

Alpha 1 antitrypsin deficiency (AATD) is an autosomal co-dominant disease linked to a mutation of the SERPINA1 gene localized to chromosome 14q32. Uniparental disomy (UPD) is known to be a genetic mechanism that causes various syndromes. Maternal UPD14 presents with a Prader-Willi syndrome-like phenotype. No publications to date have dealt with the association of these two syndromes. In this article, we report on two cases of AATD (from different families), which lead to the diagnosis of maternal UPD14. AATD was diagnosed early in both children. Their clinical presentations were typical (chronic cytolysis in patient 1 and neonatal cholestasis in patient 2); serum alpha 1 antitrypsin levels were low (P1 0.33 g/L and P2 0.35 g/L), and both patients had a Z phenotype. A pedigree study of both families showed that the father had an M phenotype and the mother an MZ phenotype, which was unexpected. On the other hand, both children were born before term and presented with symmetrical growth retardation, early eating difficulties, moderate hypotonia, understated dysmorphic features and moderate psychomotor retardation, suggestive of a Prader-Willi syndrome-like phenotype. Genotyping was performed to explain gene transmission inconsistencies, and highlighted maternal UPD 14 in both families.

Conclusion

Logically, maternal UPD 14 can induce AATD. In light of these observations, it seems appropriate to search for AATD in patients with maternal UPD 14 in order to prevent a progression of the disease. These cases also underline the significance of maternal UPD 14, which should be suspected in AATD in view of the discordance with Mendel's allelic transmission law.

Introduction

Uniparental disomy (UPD) is a genetic phenomenon that was first described by Engel [1] in 1980. It may involve any maternal or paternal chromosome. When the genes involved are imprinted, various syndromes may appear, such as Angelman syndrome (paternal UPD15), Prader-Willi syndrome (maternal UPD15) or Silver-Russel syndrome (UPD7) [2], [3]. Maternal UPD14 is known to present a Prader-Willi syndrome-like phenotype (growth retardation, neonatal hypotonia, hypoglycemia, joint hyperlaxity, eating difficulties, and precocious puberty [2], [4], [6], [7]), but pedigrees may be misinterpreted in other UPD cases.

Alpha-1 antitrypsin (AAT) is a protein which is encoded by a gene (SERPINA1) located on chromosome 14q32.1 whose alleles are co-dominant. Gene mutations can cause alpha-1 antitrypsin deficiency (AATD);, an inherited autosomal co-dominant disease.

We report on two cases (from different families) of AATD that revealed maternal UPD14. This association of maternal UPD14 and AATD has never been described previously.

Section snippets

Clinical presentations

The first patient (P1) was born at 34 weeks of gestational age and presented with moderate neonatal hypotonia, growth retardation, eating difficulties, and hypoglycemic episodes of unknown origin until the age of three years. There was no family history. AATD was diagnosed at the age of three years because of hepatomegaly (+6 centimeters below the costal margin, normal consistency) and cytolysis (transaminases at twice the upper limit of normal). Gammaglutamyl transpeptidase, total and direct

Discussion

These two observations raise the question of a link between maternal UPD14 and AATD and its consequences, which has never been described previously.

UPD is a mechanism of zygotic trisomy or monosomy rescue [3], leading to two homologous chromosomes coming from a single parent.

AAT is a glycoprotein that is encoded by a gene located on chromosome 14. Its allelic expression is based on an autosomal co-dominant pattern and the most frequent deficient alleles are PI*S and PI*Z. AATD can induce two

Conclusion

We report on the first descriptions of maternal UPD14 associated with AATD. We are unaware of the prevalence of this association.

It therefore seems appropriate to propose systematic testing for AATD when a Prader-Willi syndrome-like phenotype (maternal UPD 14) is observed. An early diagnosis of AATD may help prevent or limit progression of the disease (by ensuring adequate follow-up, prevention of smoking or alcohol consumption, etc.) and is paramount because this condition can easily go

Disclosure of interest

The authors declare that they have no conflicts of interest concerning this article.

References (7)

  • K. Hoffmann et al.

    Uniparental disomies 7 and 14

    Best Pract Res Clin Endocrinol Metab

    (2011)
  • E. Engel

    A new genetic concept: uniparental disomy and its potential effect, isodisomy

    Am J Med Genet

    (1980)
  • D.H. Siegel et al.

    Uniparental disomy

    Pediatr Dermatol

    (2005)
There are more references available in the full text version of this article.
View full text